Pfizer Inc.PFENYSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank62
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P62
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 3.89% |
| Q3 2025 | -0.70% |
| Q2 2025 | -22.69% |
| Q1 2025 | -19.23% |
| Q4 2024 | 15.24% |
| Q3 2024 | 164.40% |
| Q2 2024 | -58.78% |
| Q1 2024 | 460.97% |
| Q4 2023 | 57.98% |
| Q4 2023 | -227.86% |
| Q3 2023 | -64.83% |
| Q2 2023 | 25.00% |
| Q4 2022 | -44.86% |
| Q4 2022 | -25.09% |
| Q3 2022 | 28.92% |
| Q2 2022 | 206.19% |
| Q4 2021 | -57.68% |
| Q4 2021 | 29.43% |
| Q3 2021 | 24.46% |
| Q2 2021 | 422.37% |
| Q4 2020 | -63.16% |
| Q3 2020 | -0.44% |
| Q2 2020 | -19.10% |
| Q1 2020 | 51.86% |
| Q4 2019 | -39.33% |
| Q3 2019 | -19.84% |
| Q2 2019 | -6.58% |
| Q1 2019 | 38.22% |
| Q4 2018 | -16.45% |
| Q3 2018 | -4.11% |
| Q3 2018 | 0.37% |
| Q2 2018 | 62.96% |
| Q4 2017 | -36.00% |
| Q4 2017 | 0.21% |
| Q3 2017 | -6.72% |
| Q2 2017 | 63.02% |
| Q4 2016 | -30.71% |
| Q4 2016 | -3.08% |
| Q3 2016 | -5.93% |
| Q2 2016 | 78.33% |